Delivery Order SPE2DB20D1102-SPE2DB25FC6QK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,623.32 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily in the treatment of tuberculosis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for Rifampin 150 mg capsules (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin Capsules under a firm fixed-price contract valued at $358,753.20. The contract, which carries no set-aside designation, is effective through July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic medication used in the treatment of tuberculosis and other mycobacterial...
- The Defense Logistics Agency awarded a delivery order valued at $4,763.19 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Rifampin 300 mg capsules (60-count). The contract employs firm fixed pricing and is scheduled for completion by July 24, 2025, with performance to occur at the contractor's Conshohocken, Pennsylvania facility. This is a non-set-aside, competitively awarded delivery order without disadvantaged business enterprise restrictions. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 capsules of 300 mg Rifampin, an antibiotic medication, with a ceiling value of $10,237.44. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,243,500 units of Rifampin 300 mg capsules. The award has a ceiling value of $61,426.00 and a period of performance through July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Rifampin 300 mg capsules. The firm-fixed-price contract has a ceiling value of $10,688.90 and a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,673.45 firm fixed-price delivery order is for the supply of 60 capsules of the antibiotic Rifampin 300mg. The contract has an ultimate completion date of March 12, 2025 and was awarded on February 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6QKDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. This firm fixed-price delivery order carries a ceiling value of $7,920.22 and is scheduled for ultimate completion by July 23, 2025. The contract represents a non-competitive, non-set-aside award with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic commonly used in the treatment of tuberculosis and other mycobacterial infections, making this procurement essential for military and veteran healthcare supply needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a prime vendor for the Defense Health Agency and broader federal military healthcare systems, providing access to a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies. The company's role as a global pharmaceutical support vehicle enables efficient delivery of critical medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/22/25 |